GIA
AXSM icon

GHP Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History

GHP Investment Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170 Buy
+1
New +$173 ﹤0.01% 1234
2025
Q4 		– Sell
-6
Closed -$729 – 987
2025
Q3 		$729 Buy
+6
New +$676 ﹤0.01% 898

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GHP Investment Advisors's AXSM Position: Q1 2026 in Review

GHP Investment Advisors opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 1 share worth $170. The stake represents ﹤0.01% of the portfolio and ranks #1234 among its holdings. This is a return to the name: GHP Investment Advisors previously reported a position in AXSM as recently as Q3 2025.

GHP Investment Advisors first reported a position in AXSM in Q3 2025 and has held it in 2 quarters since. The position peaked at $729 in Q3 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • GHP Investment Advisors held 1 share of Axsome Therapeutics worth $170 as of Q1 2026.
  • Axsome Therapeutics was a new GHP Investment Advisors position in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of GHP Investment Advisors's portfolio in Q1 2026, its #1234 holding.
  • GHP Investment Advisors first reported a position in Axsome Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • GHP Investment Advisors's Axsome Therapeutics position peaked at $729 in Q3 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on GHP Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.